https://www.selleckchem.com/pr....oducts/sovilnesib.ht
Most (28/57) reported on HIV testing in TB. No reports on HIV testing in VC/VIN2+ or PN patients were eligible for inclusion. Large variation in HIV test ratios was observed between and within ICs, resulting from different testing approaches. Highest HIV test ratios (pooled ratio 0·72, 95%CI 0·63-0·8 and positivity (0·05, 95% CI 0·03-0·06) were observed among TB patients, and lowest among CC/CIN2+ patients (pooled ES test ratio 0·12, 95%CI 0·01-0·31, positivity 0·00, 95%CI 0·00-0·0. IC-guided HIV testing is insufficiently impleme